Advaxis, Inc. (ADXS) SEC filings
ADXS SEC filings moved a median of -1.24% by the close. ADXS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ADXS overview →
20 measured ADXS SEC filing events.
Where these ADXS SEC filings landedvs 19 measured ADXS SEC filing reactions
| Middle 50% of ADXS SEC filing reactions | -7.77% to +1.06% |
|---|---|
| Median reaction (to close) | -1.24% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 ADXS SEC filing events with a measured close landed between -7.77% and +1.06%; 26% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations | Press release | -3.85% | -15.96% | |
| Form 15-12G Ayala Pharmaceuticals, | SEC filing · Form 15-12G | -3.85% | -15.96% | |
| Form 10-K/A Ayala Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +19.82% | |
| Form 8-K/A Ayala Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | +0.00% | -4.67% | |
| Form 10-K Ayala Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.69% | |
| Form S-8 POS Ayala Pharmaceuticals, | SEC filing · Form S-8 | -12.05% | -12.21% | |
| Form 8-K Ayala Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | +0.00% | -9.40% | |
| Form NT 10-K Ayala Pharmaceuticals, For: Apr 01 | SEC filing · Form NT | +0.00% | +0.00% | |
| Form 8-K Ayala Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | — | — | |
| Form 8-K Ayala Pharmaceuticals, For: Mar 01 | SEC filing · Form 8-K | +0.00% | -6.13% | |
| Form DEFM14C Ayala Pharmaceuticals, | SEC filing · Form DEFM14C | +6.25% | -4.47% | |
| Form 8-K Ayala Pharmaceuticals, For: Feb 20 | SEC filing · Form 8-K | +0.00% | +2.11% | |
| Form PREM14C Ayala Pharmaceuticals, For: Feb 20 | SEC filing · Form PREM14C | +0.00% | +21.76% | |
| Form 8-K Ayala Pharmaceuticals, For: Feb 07 | SEC filing · Form 8-K | -13.33% | -12.38% | |
| Form 8-K Ayala Pharmaceuticals, For: Feb 05 | SEC filing · Form 8-K | +30.82% | +41.64% | |
| Form 8-K/A Ayala Pharmaceuticals, For: Oct 18 | SEC filing · Form 8-K | +0.00% | -3.66% | |
| Form 10-Q Ayala Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form NT 10-Q Ayala Pharmaceuticals, For: Nov 14 | SEC filing · Form NT | +0.00% | -1.24% | |
| Form D Ayala Pharmaceuticals, | SEC filing · Form D | +0.00% | +5.01% | |
| Form 8-K Ayala Pharmaceuticals, For: Oct 18 | SEC filing · Form 8-K | +5.56% | +0.00% |
Keep exploring
More ADXS: earnings → · analyst actions → · ADXS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) | 49 | -0.01% | 17% |
| Valion Bio, Inc. (VBIO) | 49 | 0.00% | 49% |
| Arch Biopartners Inc (ARCH_CDNX) | 48 | -0.59% | 19% |
| SINO BIOPHARM ORD (SBMFF) | 48 | 0.00% | 4% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.